Evidence map›Paper›PMID 42768015›Full record

ArticleNature communications2026

Data-driven construction of an imine reductase library capable of broad-scope reductive amination at equimolar substrate concentrations.

Sarah A Berger, Christopher Grimm, Marco Cespugli, Andreas Krassnigg, Tobias Schopper, Irene Marzuoli, Isabel Oroz-Guinea, Stephan Vrabl, Lukas Roemer, Melanie A Weber and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sarah A Berger *Department of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.
Christopher Grimm *Department of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.ORCID http://orcid.org/0000-0002-2874-7101
Marco CespugliInnophore GmbH, Am Eisernen Tor 3, Graz, Austria.ORCID http://orcid.org/0000-0003-2818-158X
Andreas KrassniggInnophore GmbH, Am Eisernen Tor 3, Graz, Austria.
Tobias SchopperInnophore GmbH, Am Eisernen Tor 3, Graz, Austria.
Irene MarzuoliProcess Chemistry and Catalysis, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, Switzerland.
Isabel Oroz-GuineaDepartment of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.ORCID http://orcid.org/0000-0001-6989-3597
Stephan VrablDepartment of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.
Lukas RoemerDepartment of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.
Melanie A WeberDepartment of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.
Fabian M KulierDepartment of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.ORCID http://orcid.org/0009-0001-3618-824X
Yuliya OrelDepartment of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.
Bettina M NestlInnophore GmbH, Am Eisernen Tor 3, Graz, Austria.
Christian C GruberInnophore GmbH, Am Eisernen Tor 3, Graz, Austria.
Georg SteinkellnerInnophore GmbH, Am Eisernen Tor 3, Graz, Austria.ORCID http://orcid.org/0000-0001-7565-8868
Serena BisagniProcess Chemistry and Catalysis, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, Switzerland.
Francis GosselinDepartment of Small Molecule Process Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA, USA.
Hans IdingProcess Chemistry and Catalysis, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, Switzerland.
Kurt PuentenerProcess Chemistry and Catalysis, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, Switzerland.
Dennis WetzlProcess Chemistry and Catalysis, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, Switzerland.
Wolfgang KroutilDepartment of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria.ORCID http://orcid.org/0000-0002-2151-6394
Joerg H SchrittwieserDepartment of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz, Austria. joerg.schrittwieser@uni-graz.at.ORCID http://orcid.org/0000-0002-5780-3221

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reductive amination catalysed by imine reductases and reductive aminases has emerged as a powerful method for the asymmetric synthesis of chiral amines, yet the generality and practical limitations of these enzymes remain poorly understood. Here, we combine large-scale, iterative activity screening, sequence analysis and machine-learning-guided exploration to systematically profile reductive amination performance across 175 enzymes and structurally diverse substrate panels. We show that asymmetric reductive amination at equimolar substrate concentrations is widespread within this enzyme family and assemble catalysts that display broad scope, high specific activity and excellent stereoselectivity. Sequence-level analysis identifies characteristic features associated with broad-scope reductive aminases and pinpoints key residues governing stereoselectivity, while machine-learning models trained on the screening data enable successful prediction of enzyme activity for previously untested substrate combinations. Selected reactions were scaled to a preparative batch size, affording gram quantities of optically pure amine products.

Indexed as

IminesOxidoreductasesAminationAminesOxidation-ReductionStereoisomerismSubstrate SpecificityAminesIminesOxidoreductases

Identifiers

PMID42768015
PMCPMC13594329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.